Covered recipient · General Payments record
BURHAN ZAFAR CHAUDHRY
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018
$527.93
- Reported across 9 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2018 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $377.93 | 8 |
| Consulting Fee | $150.00 | 1 |
By paying entity
PY2018 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Biogen, Inc. | $211.02 | 2 |
| Celgene Corporation | $110.48 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $89.71 | 1 |
| GENZYME CORPORATION | $66.88 | 2 |
| Sunovion Pharmaceuticals Inc. | $49.84 | 2 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2018 | $527.93 | 9 |
Payment records · PY2018 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Biogen, Inc. | $150.00 | 03/28/2018 | Consulting Fee | Undisputed | 01/23/2026 | 553707569 | CMS |
| Biogen, Inc. | $61.02 | 05/31/2018 | Food and Beverage | Undisputed | 01/23/2026 | 553707549 | CMS |
| Celgene Corporation | $57.18 | 02/08/2018 | Food and Beverage | Undisputed | 01/23/2026 | 595036403 | CMS |
| Celgene Corporation | $53.30 | 05/24/2018 | Food and Beverage | Undisputed | 01/23/2026 | 595167121 | CMS |
| GENZYME CORPORATION | $47.88 | 02/21/2018 | Food and Beverage | Undisputed | 01/23/2026 | 602116308 | CMS |
| GENZYME CORPORATION | $19.00 | 06/20/2018 | Food and Beverage | Undisputed | 01/23/2026 | 602368393 | CMS |
| Novartis Pharmaceuticals Corporation | $89.71 | 05/31/2018 | Food and Beverage | Undisputed | 01/23/2026 | 607956071 | CMS |
| Sunovion Pharmaceuticals Inc. | $19.77 | 01/23/2018 | Food and Beverage | Undisputed | 01/23/2026 | 607214141 | CMS |
| Sunovion Pharmaceuticals Inc. | $30.07 | 05/11/2018 | Food and Beverage | Undisputed | 01/23/2026 | 595666151 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018
- Source files
- Dataset page · Bulk file · PY2018
- Generated from
- OP_DTL_GNRL_PGYR2018_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.